• Ontario pharmacists can now assess and prescribe for 13 minor ailments as of January 1, 2023. This service will now be available directly via Mednow.ca and the Mednow Pharmacy App
  • As part of the new update of the application, Mednow also adds single sign-on capabilities
  • Medication reconciliations are now also available via the Mednow platform

Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy is pleased to release a suite of new features for its Web, iOS, and Android virtual pharmacy applications. As of January 1st, pharmacists in Ontario were able to better support patients by assessing and prescribing treatment for 13 minor conditions. These conditions include hives, cold sores, urinary tract infections and pink eye, among others. These services are available for patients with a valid Ontario health card. There is no out-of-pocket charge for patients as this initiative is publicly funded. Mednow users via web account or downloadable application can now access a virtual pharmacist consultation and, if appropriate, receive a prescription for 13 minor ailments.

"Mednow’s mission has always been to empower underutilized pharmacists and technology to improve the health of Canadians. We believe a pharmacist prescribing for minor ailments via mobile app is a perfect example," said Ali Reyhany, CEO and Co-Founder of Mednow. "This is also a great example of the government embracing innovative models to bring health care efficiency to the system. Mednow is proud to offer Ontarians with increased access to healthcare at no cost to the user while, perhaps, saving them a trip to a walk-in clinic,” said Ali Reyhany.

The Company also released single sign-on (SSO) for its enterprise clients through its Mednow for Business offering. SSO is an identification method that enables users to log in to multiple applications and websites with one set of credentials. SSO streamlines the authentication process for users, usually between organizations. As more organizations are looking for seamless integrations of services in a digital environment, Mednow integrates itself into platforms driving better patient experiences and cross-platform synergies. The Company intends to use this feature with patient care organizations as well as payors who are increasingly looking for personalized and seamless user experiences while prioritizing health and wellness.

“We are beginning to see digital collaboration between stakeholders in pharmacy in Canada. Our product roadmap is influenced by learnings in the industry aimed at solving real problems for our customers, whether that customer is an individual or an organization,” said Dave Marantz, Chief Revenue Officer of Mednow.

Mednow patients can also now receive medication reconciliation via the Mednow platform. Overall, one-on-one medication review and reconciliation by a pharmacist can lead to improved medication adherence, better health outcomes, increased patient safety, enhanced patient education, and improved medication management. These benefits can ultimately result in reduced healthcare costs and increased patient satisfaction. “As a digital pharmacy, we aim to leverage technology to make these benefits more accessible and convenient for Canadians,” said Ali Reyhany.

About Mednow

Mednow (TSXV: MNOW) (OTCQX: MDNWF) is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home delivery of medications, doctor consultations, a user-friendly interface for easy upload, transfer, and refill of prescriptions, access to healthcare professionals through an intuitive chat experience and the specialized PillSmart™ system that packages prescriptions in easy to use daily dose packs, each labeled with the date and time of the next dose.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements:

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding the Company’s intention to use the SSO with patient care organizations and payors, is a forward-looking statement and contains forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release including that the Company will use the SSO with patient care organizations and payors. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, that the Company will not use the SSO with patient care organizations and payors as anticipated by management or at all. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

Investor contact: Lorraine Cardenas 1-855-686-6300 ir@mednow.ca

Mednow (TSXV:MNOW)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas Mednow.
Mednow (TSXV:MNOW)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas Mednow.